Kristalose as Bowel Evacuant Prior to Colonoscopy
A Single Center, Open-Label, Pilot Study to Determine the Safety, Efficacy, and Patient Preference of Kristalose as a Bowel Evacuant Prior to Colonoscopy
A Single Center, Open-Label, Pilot Study to Determine the Safety, Efficacy, and Patient Preference of Kristalose as a Bowel Evacuant Prior to Colonoscopy
Sponsor study identifier
interventional
20
1 country
1
Study Start
December 2010
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
September 2011
Actual (reported)Study Completion
September 2011
Actual (reported)To determine whether Kristalose causes a significant increase in hydrogen and/or methane gas levels in patients requiring bowel evacuation, and also to determine the safety, efficacy, and patient preference of Kristalose as a bowel evacuant
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 2011
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 2010
Date type not reportedThis date has not been verified as actual or estimated.
December 7, 2010
Actual (reported)December 8, 2010
Actual (reported)September 2011
Actual (reported)September 2011
Actual (reported)Hydrogen and Methane Gas Production
To evaluate the primary objective of hydrogen and methane gas production as measured by: • Pre- and post-dose breath analysis for hydrogen and methane gas.
3 months
Efficacy
3 months
Kristalose as Bowel Evacuant
The dosing regimen of Kristalose will be nine 20-gram doses (one dose every 30 minutes for 4 straight hours) taken the evening before the colonoscopy procedure.
Virginia Mason Medical Center
Seattle, Washington, 98101, United States
First Submitted
December 7, 2010
First Posted
December 8, 2010
Study Start
December 2010
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
September 2011
Actual (reported)Pilot Study of the Effect of Lactulose on Post Caesarean Section Constipation
Intravenous Branched Chain Amino Acids for Hepatic Encephalopathy in ACLF
Contact the study team to confirm eligibility.
Study Completion
September 2011
Actual (reported)Last Updated
October 6, 2011
Record last verified: 2011-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: